U.S., Nov. 21 -- ClinicalTrials.gov registry received information related to the study (NCT07951476) titled 'Comparing Itraconazole Alone With Itraconazole Plus Terbinafine for Adults With Resistant Tinea Corporis' on Nov. 16.
Brief Summary: This randomized controlled study will compare the effectiveness of oral itraconazole alone with a combination of oral itraconazole and terbinafine in adults with resistant tinea corporis (ringworm of the body). Resistant tinea corporis is a fungal skin infection that persists despite appropriate topical antifungal treatment or returns shortly after treatment.
Eligible patients aged 18-60 years with resistant tinea corporis confirmed by potassium hydroxide (KOH) microscopy will be randomly assigned to ...